A 45-Year-Old Man with Weakness and Myalgia After Orthopedic Surgery Rocio Vazquez Do Campo, Jason Siegel, Eric Goldstein, Et Al

Total Page:16

File Type:pdf, Size:1020Kb

A 45-Year-Old Man with Weakness and Myalgia After Orthopedic Surgery Rocio Vazquez Do Campo, Jason Siegel, Eric Goldstein, Et Al RESIDENT & FELLOW SECTION Clinical Reasoning: Section Editor A 45-year-old man with weakness and John J. Millichap, MD myalgia after orthopedic surgery Rocio Vazquez do SECTION 1 On examination, the patient had tenderness in Campo, MD A 45-year-old man underwent rotator cuff surgery and both thighs. There were no skin changes, swelling, Jason Siegel, MD developed fatigue and generalized myalgia postopera- or erythema. He had multiple surgical scars in the Eric Goldstein, MD tively. After 4 weeks of mild symptoms, he experienced right shoulder and mild weakness in proximal limb Elliot Dimberg, MD severe muscle aches and bilateral leg weakness after walk- and cervical muscles. Biceps and patellar reflexes were ing 1.5 miles, prompting him to seek medical attention. diminished bilaterally. He was able to rise from a chair The patient had a history of chronic pain syn- using his arms, but had difficulty ambulating due to Correspondence to drome and multiple orthopedic surgeries. He had leg pain. The remainder of the examination was Dr. Vazquez do Campo: no pertinent family history. He denied foreign travel, vazquezdocampo.rocio@mayo. unremarkable. edu consumption of alcohol, tobacco, illicit drugs, nutri- Questions for consideration: tional supplements, or herbal remedies. He denied risky sexual behaviors. He was taking trazodone, oxy- 1. What is the differential diagnosis? codone, and omeprazole. 2. What studies should be obtained next? GO TO SECTION 2 From the Department of Neurology, Mayo Clinic Jacksonville, FL. Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article. © 2017 American Academy of Neurology e185 ª 2017 American Academy of Neurology. Unauthorized reproduction of this article is prohibited. SECTION 2 given the diffuse nature of the symptoms. Due to the This patient presents with diffuse myalgia after patient’s history of chronic pain, fibromyalgia and a minimally invasive surgical procedure and is found polymyalgia rheumatica are possible, but objective to have mild proximal weakness on examination. Myal- weakness would not be expected. Finally, acute pain gia, or muscle pain, is encountered in a variety of condi- exacerbation and deconditioning after surgery are tions, ranging from benign causes, such as strenuous diagnoses of exclusion. physical activity, to life-threatening conditions. The first Initial laboratory evaluation in patients with myal- step in the evaluation of patients with myalgia is to estab- gia should include complete blood count, serum cal- lish a timeframe from symptom onset and precipitating cium and other electrolytes, urinalysis, renal and liver factors. Acute onset is observed after trauma, surgery, or function tests, thyroid-stimulating hormone (TSH), strenuous exercise. If symptoms develop insidiously, and creatinine kinase (CK) levels. Depending on medications (statins, fibrates), rheumatologic conditions other symptoms, risk factors, and examination find- (polymyalgia rheumatica), chronic infections, or meta- ings, blood cultures, erythrocyte sedimentation rate bolic disorders (hypercalcemia, hypothyroidism, or hy- (ESR), C-reactive protein (CRP), or rheumatologic percortisolism) should be considered. studies may be helpful. The distribution of myalgia helps narrow the differ- In this patient, blood count and chemistries were ential diagnosis. Myalgia involving proximal appendic- normal. CK levels were elevated at 86,300 U/L ular muscles points towards a primary muscle disease (normal ,330 U/L). Transaminases were also elevated: or rheumatologic or orthopedic disorders. When dif- alanine aminotransferase (ALT) was 1,260 U/L (normal fuse, an infectious process, especially viral and parasitic, ,55 U/L) and aspartate aminotransferase (AST) was deserves consideration. Rhabdomyolysis from varied 3,270 U/L (normal ,48 U/L). Lactate dehydrogenase etiologies can also present with diffuse myalgia.1,2 (LDH) was 1,360 U/L (normal ,220 U/L). Alkaline Detection of objective weakness is important, but phosphatase and g-glutamine transpeptidase (GGT) frequently confounded by pain limiting maximal levels were normal. Urine dipstick revealed proteinuria effort on examination. Assessment of neck flexors and was positive for blood (1–3 erythrocytes per high- and extensors may be helpful. Both myopathies and powered field on microscopy). ESR and CRP were polyradiculopathies can present with weakness and moderately elevated. TSH was normal. Hepatitis serol- pain in proximal limbs. In this patient, sensation ogies, HIV, procalcitonin, blood cultures, and urine was preserved and reflexes mildly diminished, more drug screen were negative. suggestive of a myopathy. The temporal relationship Questions for consideration: with a surgical procedure requires exclusion of an in- traoperative or postoperative infection or an underly- 1. How do you interpret these results? ing metabolic or endocrine disorder exacerbated by 2. What information would help narrow the differ- surgical stress. Direct trauma from surgery is unlikely ential diagnosis? GO TO SECTION 3 e186 Neurology 88 May 9, 2017 ª 2017 American Academy of Neurology. Unauthorized reproduction of this article is prohibited. SECTION 3 muscle enzymes, myoglobinuria, and generalized The patient had markedly elevated CK, AST, ALT, myalgia. The elevated ESR and CRP likely resulted and LDH levels. These enzymes are present in skele- from an inflammatory response to muscle injury. tal muscle cells and are released into the circulation as The most important next step was to provide IV the result of muscle damage and membrane disrup- hydration to preserve renal function and to exclude tion as seen in rhabdomyolysis. Transaminases and life-threatening complications (cardiac arrhythmias LDH are also found in liver tissue, but in the presence from electrolyte disturbances, severe metabolic acido- of hyperCKemia, these enzyme elevations are more sis, and organ failure). likely due to muscle breakdown than liver injury. In Once stabilized, the patient reported recurrent ep- addition, GGT and alkaline phosphatase, more spe- isodes of diffuse muscle aches and occasional dark cific markers of liver damage, were normal in this urine, which would subside within hours to days, patient. Other muscle components, including myo- after exercise dating back to his teenage years. He globin and other small proteins, are also released in experienced similar symptoms episodically in the con- the setting of muscle breakdown and excreted in text of surgical procedures and illnesses. Over the past urine resulting in proteinuria. Myoglobin has molec- year, he had developed exercise intolerance and could ular similarities with hemoglobin and also turns urine not walk more than 150 yards without experiencing dark; therefore the presence of myoglobin in urine severe leg pain. may be falsely labeled as hematuria. A few erythro- Questions for consideration: cytes under direct urine visualization, like in this patient, suggests myoglobinuria. 1. What are common causes of rhabdomyolysis? We concluded that our patient had rhabdomyoly- 2. What is the most likely cause of rhabdomyolysis in sis causing increased serum levels of CK and other this patient? GO TO SECTION 4 Neurology 88 May 9, 2017 e187 ª 2017 American Academy of Neurology. Unauthorized reproduction of this article is prohibited. SECTION 4 metabolism. While in glycolytic metabolic defects, The causes of rhabdomyolysis can be divided into 3 patients usually have cramps induced by light exer- categories: traumatic, exertional, and nontraumatic cise or brief isometric contractions, symptoms in nonexertional. Trauma includes direct muscle dam- disorders of lipid metabolism are dominated by age or compression from prolonged immobilization myalgia triggered by prolonged or intense exercise against a hard surface. The second category includes and other situations that increase energy demand conditions in which energy production or utilization from fat (fasting, fever, trauma, surgery).4,5 Symp- by myocytes is insufficient to meet metabolic de- toms in our patient were precipitated by the stress of mands, such as hyperthermia, convulsive seizure, vig- surgery and possibly intraoperative anesthetics, and orous exercise, and metabolic myopathies. The third further worsened by prolonged exertion (walking group includes miscellaneous conditions (infections, a long distance), therefore a metabolic myopathy electrolyte imbalances, drug or toxin-related, muscle due to a lipid metabolism defect was suspected. ischemia, or inflammatory myopathies).3 We ordered serum levels of free and total carnitine, The cause of rhabdomyolysis in this patient falls acylcarnitines, and urine organic acids. Concentra- into the second category. He had a longstanding his- tions of long-chain acylcarnitines, particularly C16 tory of exercise intolerance beginning in childhood and C18:1 species, were elevated with an otherwise with recurrent myalgia and pigmenturia triggered normal carnitine profile (total plasma 76 nmol/mL by exercise and stress, suggesting a disorder of [normal 34–78 nmol/mL]). Further serologic meta- energy metabolism. In addition, after the attack bolic screening was unremarkable. Electrodiagnostic his strength improved and muscle enzymes normal- studies and muscle biopsy were deferred as both ized, indicating cessation of damage after resolution provide limited information in the setting of rhab- of the situation of metabolic stress. These features
Recommended publications
  • Aetiology of Fibrositis
    Ann Rheum Dis: first published as 10.1136/ard.6.4.241 on 1 January 1947. Downloaded from AETIOLOGY OF FIBROSITIS: A REVIEW BY MAX VALENTINE From a review of systems of classification of fibrositis (National Mineral Water Hospital, Bath, 1940; Devonshire Royal Hospital, Buxton, 1940; Ministry of Health Report, 1924; Harrogate Royal Bath Hospital Report, 1940; Ray, 1934; Comroe, 1941 ; Patterson, 1938) the one in use at the National Mineral Water Hospital, Bath, is considered most valuable. There are five divisions of fibrositis as follows: (a) intramuscular, (b) periarticular, (c) bursal and tenosynovial, (d) subcutaneous, (e) perineuritic, the latter being divided into (i) brachial (ii) sciatic, etc. Laboratory Tests No biochemical abnormalities have been demonstrated in fibrositis. Mester (1941) claimed a specific test for " rheumatism ", but Copeman and Stewart (1942) did not find it of value and question its rationale. The sedimentation rate is usually normal or may be slightly increased; this is confirmed by Kahlmeter (1928), Sha;ckle (1938), and Dawson and others (1930). Miller copyright. and Gibson (1941) found a slightly increased rate in 52-3% of patients, and Collins and others (1939) found a (usually) moderately increased rate in 35% of cases tested. Case Analyses In an investigation Valentine (1943) found an incidence of fibrositis of 31-4% (60% male) at a Spa hospital. (Cf. Ministry of Health Report, 1922, 30-8%; Buxton Spa Hospital, 1940, 49 5%; Bath Spa Hospital, 1940, 22-3%; Savage, 1941, 52% in the Forces.) Fibrositis was commonest http://ard.bmj.com/ between the ages of40 and 60; this is supported by the SpaHospital Report, Buxton, 1940.
    [Show full text]
  • Clinical Data Mining Reveals Analgesic Effects of Lapatinib in Cancer Patients
    www.nature.com/scientificreports OPEN Clinical data mining reveals analgesic efects of lapatinib in cancer patients Shuo Zhou1,2, Fang Zheng1,2* & Chang‑Guo Zhan1,2* Microsomal prostaglandin E2 synthase 1 (mPGES‑1) is recognized as a promising target for a next generation of anti‑infammatory drugs that are not expected to have the side efects of currently available anti‑infammatory drugs. Lapatinib, an FDA‑approved drug for cancer treatment, has recently been identifed as an mPGES‑1 inhibitor. But the efcacy of lapatinib as an analgesic remains to be evaluated. In the present clinical data mining (CDM) study, we have collected and analyzed all lapatinib‑related clinical data retrieved from clinicaltrials.gov. Our CDM utilized a meta‑analysis protocol, but the clinical data analyzed were not limited to the primary and secondary outcomes of clinical trials, unlike conventional meta‑analyses. All the pain‑related data were used to determine the numbers and odd ratios (ORs) of various forms of pain in cancer patients with lapatinib treatment. The ORs, 95% confdence intervals, and P values for the diferences in pain were calculated and the heterogeneous data across the trials were evaluated. For all forms of pain analyzed, the patients received lapatinib treatment have a reduced occurrence (OR 0.79; CI 0.70–0.89; P = 0.0002 for the overall efect). According to our CDM results, available clinical data for 12,765 patients enrolled in 20 randomized clinical trials indicate that lapatinib therapy is associated with a signifcant reduction in various forms of pain, including musculoskeletal pain, bone pain, headache, arthralgia, and pain in extremity, in cancer patients.
    [Show full text]
  • Employees Calling About RTW Clearance
    1. Employee should do home quarantine for 7 days Employees calling and consult their physician about RTW clearance 2. Employee must call their own manager to call in Community/General Exposure OR sick as per their usual policy IP&C or Supervisor Confirmed Exposure 3. To return to work, employee must be fever-free without antipyretic for 3 days (72 hours) AND 1. Confirm that employee symptoms improveD AND finisheD 7-day home has finished 7-day home quarantine Community/General/ Travel/ quarantine AND fever-free Day Zero= First Day of Symptoms without antipyretics for 3 CDC Level 2/3 Country* COVID Permitted work on the 8th day days (72 hours) AND Exposure Employee must call the WHS hotline back symptoms have improved then for RTW clearance Employees who call-in 2. Employee should wear Community/General/ 4.Fill out RTW form to place employee off-duty with non-CLI surgical face mask during Unknown COVID Symptoms, but still entire shift while at work exposure (any not feeling well: going forward 3. If employee has been off- exposure that is NOT Please remember to stay duty for 8 or more calendar “Infection Prevention home if you don’t feel days, then email and Control (IP&C) well. Healthcare team confirmed) [email protected] Personnel must not work with doctor’s note simply sick. Follow usual steps stating that they sought for take sick day and care/treatment for COVID- contact their manager. Note: loss of smell/taste alone does If there are NO like symptoms ANY 4.Employee should update NOT constitute CLI per WHS No RTW form needed for symptoms following their manager COVID-19 Symptoms: guidelines Employees with NO non-CLI exposure or travel, 5.
    [Show full text]
  • Oral Health Fact Sheet for Dental Professionals Adults with Type 2 Diabetes
    Oral Health Fact Sheet for Dental Professionals Adults with Type 2 Diabetes Type 2 Diabetes ranges from predominantly insulin resistant with relative insulin deficiency to predominantly an insulin secretory defect with insulin resistance, American Diabetes Association, 2010. (ICD 9 code 250.0) Prevalence • 23.6 million Americans have diabetes – 7.8% of U.S. population. Of these, 5.7 million do not know they have the disease. • 1.6 million people ≥20 years of age are diagnosed with diabetes annually. • 90–95% of diabetic patients have Type 2 Diabetes. Manifestations Clinical of untreated diabetes • High blood glucose level • Excessive thirst • Frequent urination • Weight loss • Fatigue Oral • Increased risk of dental caries due to salivary hypofunction • Accelerated tooth eruption with increasing age • Gingivitis with high risk of periodontal disease (poor control increases risk) • Salivary gland dysfunction leading to xerostomia • Impaired or delayed wound healing • Taste dysfunction • Oral candidiasis • Higher incidence of lichen planus Other Potential Disorders/Concerns • Ketoacidosis, kidney failure, gastroparesis, diabetic neuropathy and retinopathy • Poor circulation, increased occurrence of infections, and coronary heart disease Management Medication The list of medications below are intended to serve only as a guide to facilitate the dental professional’s understanding of medications that can be used for Type 2 Diabetes. Medical protocols can vary for individuals with Type 2 Diabetes from few to multiple medications. ACTION TYPE BRAND NAME/GENERIC SIDE EFFECTS Enhance insulin Sulfonylureas Glipizide (Glucotrol) Angioedema secretion Glyburide (DiaBeta, Fluconazoles may increase the Glynase, Micronase) hypoglycemic effect of glipizide Glimepiride (Amaryl) and glyburide. Tolazamide (Tolinase, Corticosteroids may produce Diabinese, Orinase) hyperglycemia. Floxin and other fluoroquinolones may increase the hypoglycemic effect of sulfonylureas.
    [Show full text]
  • Chronic Pelvic Pain & Pelvic Floor Myalgia Updated
    Welcome to the chronic pelvic pain and pelvic floor myalgia lecture. My name is Dr. Maria Giroux. I am an Obstetrics and Gynecology resident interested in urogynecology. This lecture was created with Dr. Rashmi Bhargava and Dr. Huse Kamencic, who are gynecologists, and Suzanne Funk, a pelvic floor physiotherapist in Regina, Saskatchewan, Canada. We designed a multidisciplinary training program for teaching the assessment of the pelvic floor musculature to identify a possible muscular cause or contribution to chronic pelvic pain and provide early referral for appropriate treatment. We then performed a randomized trial to compare the effectiveness of hands-on vs video-based training methods. The results of this research study will be presented at the AUGS/IUGA Joint Scientific Meeting in Nashville in September 2019. We found both hands-on and video-based training methods are effective. There was no difference in the degree of improvement in assessment scores between the 2 methods. Participants found the training program to be useful for clinical practice. For both versions, we have designed a ”Guide to the Assessment of the Pelvic Floor Musculature,” which are cards with the anatomy of the pelvic floor and step-by step instructions of how to perform the assessment. In this lecture, we present the video-based training program. We have also created a workshop for the hands-on version. For more information about our research and workshop, please visit the website below. This lecture is designed for residents, fellows, general gynecologists,
    [Show full text]
  • Musculoskeletal Pain
    Musculoskeletal Pain Kathryn Albers Mechanisms and Clinical Presentation of Pain November 4, 2019 Queme et al., (2017). Peripheral mechanisms of ischemic myalgia. Frontiers in Cellular Neuroscience. Mense et al., (2010). Functional anatomy of muscle: Muscle, nociceptors and afferent fibers. In MusclePain: Understanding the Mechanisms. The musculoskeletal system consists of the body's bones, muscles, tendons, ligaments, joints, and cartilage. A tendon is a fibrous connective tissue that attaches muscle to bone (serves to move the bone). A ligament is a fibrous connective tissue that attaches bone to bone (serves to hold structures together). Major health problems presenting with muscle ache/pain are addressed by NIAMS, National Institutes of Arthritis, Musculoskeletal and Skin Diseases. Neck pain Temperomandibular joint pain Fibromyalgia Shoulder pain Low back pain Skeletal muscle comprises 40% of body weight. Muscles produce several hundred myokines; cytokines, growth factors, proteoglycan peptides released by muscle cells (myocytes) in response to muscular contractions. They have autocrine, paracrine and/or endocrine effects on muscle mass, fat metabolism, inflammation…. Lee and Jun. (2019) Role of myokines in regulating skeletal muscle mass and function. Frontiers in Physiology 10. Musculoskeletal Pain Overview Physical activity leads to contraction-induced mechanical and metabolic stimuli in muscle tissue. These stimuli activate receptors on terminals of thinly myelinated and unmyelinated DRG neurons that project to the DH of the spinal cord. • Chronic muscle pain can be regional (back or neck) or whole body with tender points spread over the body (fibromyalgia). • In contrast to cutaneous nociceptive stimuli, sensations from deep tissue (muscle, vascular, fascia) pain are dull, aching and poorly localized.
    [Show full text]
  • Role of Litigation
    Spinal Cord (2000) 38, 63 ± 70 ã 2000 International Medical Society of Paraplegia All rights reserved 1362 ± 4393/00 $15.00 www.nature.com/sc Scienti®c Review Aspects of the failed back syndrome: role of litigation JMS Pearce*,1 1Hull Royal In®rmary, 304 Beverly Road, Anlaby, East Yorks HU10 7BG Objective: A review that attempts to identify the mechanism and causation of persistent or recurring low back pain. Design: A personal assessment of clinical features with a selective review of the literature. Results: Thirty to forty per cent of our population aged 10 ± 65 years report that back trouble occurs on a monthly basis and in 1% to 8% this interferes with work. A de®nite patho-anatomical cause for the pain is demonstrable in only a minority. It can be deduced that psychosocial factors, including insurance bene®ts are of importance for this variation. Conclusions: Neither non-operative nor surgical procedures have a major impact on the capacity for work in this substantial minority of backache suerers. The main risk factors identi®ed are: Wrong diagnosis, repeated medical certi®cates for sickness bene®ts, failed surgery, symptoms incongruous with signs or imaging, multiple spinal procedures, poor social support and poor motivation, psychological illness, clinical depression before or after injury or operation. Pending compensation and delays in settlement are important additional features in claimants for compensation. For patients with unproven diagnostic labels such as `pain- behaviour', no evidence exists that any type of surgery is cost eective. Spinal Cord (2000) 38, 63 ± 70 Keywords: low back pain; backache; sciatica; lumbar disk; failed back; chronic pain syndrome Introduction Thirty to 40% of our population aged 10 ± 65 years patients who undergo major spinal surgery for other report that back trouble occurs on a monthly basis and reasons, eg for a tumour, start to walk within a week in 1% to 8% this interferes with work.
    [Show full text]
  • Non-Odontogenic Toothache Caused by the Fungal Ball of Maxillary Sinus: Case Reports
    Case Report pISSN 2288-9272 eISSN 2383-8493 J Oral Med Pain 2019;44(4):174-178 JOMP https://doi.org/10.14476/jomp.2019.44.4.174 Journal of Oral Medicine and Pain Non-Odontogenic Toothache Caused by the Fungal Ball of Maxillary Sinus: Case Reports Ji-Woo Ha1, Won Jung2, Kyung-Eun Lee2, Bong-Jik Suh2 1Department of Oral Medicine, School of Dentistry, Jeonbuk National University, Jeonju, Korea 2Department of Oral Medicine, Institute of Oral Bioscience, School of Dentistry, Jeonbuk National University, Jeonju, Korea Received November 23, 2019 A fungal ball (FB) of the paranasal sinuses is a chronic, non-invasive fungal sinusitis Revised December 10, 2019 defined as the accumulation of dense aggregation of fungal hyphae in a sinus cavity. A Accepted December 10, 2019 patient with FB infection in a sinus cavity has usually non-specific symptoms such as Correspondence to: post-nasal drip, nasal congestion, headache. However, facial pain and toothache can be Bong-Jik Suh developed if FB infection is in maxillary sinus. The aim of this case report is to present two Department of Oral Medicine, School of cases of FB of the maxillary sinus which caused toothache in the upper molar region. It is Dentistry, Jeonbuk National University, 567 also to make dental practitioners consider the non-odontogenic origins of toothache and to Baekje-daero, Deokjin-gu, Jeonju 54896, Korea pay special attention to avoid unnecessary dental treatment. Tel: +82-63-250-2060 Fax: +82-63-250-2058 E-mail: [email protected] Key Words: Chronic sinusitis; Fungal ball; Non-odontogenic toothache https://orcid.org/0000-0002-1817-4645 INTRODUCTION periodontal structures, nonodontogenic origin should be considered [5,6].
    [Show full text]
  • Malaria Related Myalgia-Arthralgia: an Imported Case Report Treated with Anti-Malarial Drug
    International Journal of Basic & Clinical Pharmacology Siagian FE et al. Int J Basic Clin Pharmacol. 2020 Oct;9(10):1603-1606 http:// www.ijbcp.com pISSN2319-2003 | eISSN2279-0780 DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20203964 Case Report Malaria related myalgia-arthralgia: an imported case report treated with anti-malarial drug Forman E. Siagian1*, Ronny1, Apriani I. Sirra2, Urip Susiantoro1, Melsipa Siregar1 1Department of Parasitology and The Centre of Biomedic Research, 2Faculty of Medicine, Universitas Kristen Indonesia, Jakarta, Indonesia Received: 20 August 2020 Accepted: 28 August 2020 *Correspondence: Dr. Forman E. Siagian, Email: [email protected] Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT Malaria is still a major health problem in Indonesia, especially in endemic areas. We present an imported case of malaria with prominent subjective complaint of the patient is in the form of persistent muscles and joints pain. A 21 years old female with complaint of intermittent fever and persistent muscle joints paint since one week before seeing a doctor. She had history of repetitive attack of malaria tropica. Physical examination in general showed no clear derangements, but on thick and thin blood smear stained with Giemsa revealed malaria falciparum (+). Combo therapy of antimalarial drug soon be given and the patient healed with the disappearance of all previous complaint. Myalgia and arthralgia in case of malaria falciparum (+) might be the earliest subjective sign of rhabdomyolisis, a potentially fatal and lethal complication of malaria.
    [Show full text]
  • Fibromyalgia Syndrome: Considerations for Dental Hygienists Amber Walters Old Dominion University
    Old Dominion University ODU Digital Commons Dental Hygiene Faculty Publications Dental Hygiene 4-2015 Fibromyalgia Syndrome: Considerations for Dental Hygienists Amber Walters Old Dominion University Susan L. Tolle Old Dominion University, [email protected] Gayle M. McCombs Old Dominion University, [email protected] Follow this and additional works at: https://digitalcommons.odu.edu/dentalhygiene_fac_pubs Part of the Dental Hygiene Commons, and the Musculoskeletal Diseases Commons Repository Citation Walters, Amber; Tolle, Susan L.; and McCombs, Gayle M., "Fibromyalgia Syndrome: Considerations for Dental Hygienists" (2015). Dental Hygiene Faculty Publications. 24. https://digitalcommons.odu.edu/dentalhygiene_fac_pubs/24 Original Publication Citation Walters, A., Tolle, S.L., & McCombs, G.M. (2015). Fibromyalgia syndrome: Considerations for dental hygienists. Journal of Dental Hygiene, 89(2), 76-85. This Article is brought to you for free and open access by the Dental Hygiene at ODU Digital Commons. It has been accepted for inclusion in Dental Hygiene Faculty Publications by an authorized administrator of ODU Digital Commons. For more information, please contact [email protected]. Review of the Literature Fibromyalgia Syndrome: Considerations for Dental Hygienists Amber Walters, BSDH, MS; Susan L. Tolle, BSDH, MS; Gayle M. McCombs, BSDH, MS Introduction Abstract Fibromyalgia syndrome (FMS) is a Purpose: Fibromyalgia syndrome (FMS) is a neurosensory disor- neurosensory disorder of unknown der characterized by widespread musculoskeletal pain. Typically etiology characterized by chronic persistent fatigue, depression, limb stiffness, non-refreshing sleep musculoskeletal pain, fatigue, ten- and cognitive deficiencies are also experienced. Oral symptoms derness and sleep disturbances. and pain are common, requiring adaptations in patient manage- FMS can result in severe disability ment strategies and treatment interventions.
    [Show full text]
  • Fibromyalgia and Diffuse Myalgia
    RHEUMATOLOGY 1522–5720/05 $15.00 + .00 FIBROMYALGIA AND DIFFUSE MYALGIA James M. Gill, MD, MPH, and Anna Quisel, MD PREVALENCE, PRESENTATION, AND PROGRESSION OF THE PATIENT WITH FIBROMYALGIA Chronic pain is one of the most common complaints encountered by primary care clinicians. Often, patients present not with well localized pain but with diffuse and nonspecific myalgias. Fibromyalgia is the most common etiology for this type of pain. In community-based studies, 2% [1] and 1.2% to 6.2% of school-age children screened positive for fibromyalgia [2–4]. Women and girls are at higher risk than males, and risk increases with age, peaking between 55 and 79 years [1,5]. Persons suffering from fibromyalgia most commonly complain of widespread pain. The pain is usually bilateral and is usually worse in the neck and trunk [6]. Additional symptoms include fatigue, waking unrefreshed, morning stiffness, paresthesias, and headaches [6–12]. Compared with patients with other rheumatologic conditions, persons with fibromyalgia more often suffer from comorbid conditions [13], including chronic fatigue syndrome, migraine headaches, irritable bowel syndrome, irritable bladder symptoms, temporomandibular joint syn- drome, myofascial pain syndrome, restless leg syndrome, and affective disorders [13–15]. Fibromyalgia can cause significant morbidity [1,16,17]. Patients with fibromyalgia require an average of 2.7 drugs at any time for fibromyalgia- related symptoms and have an average of 10 outpatient visits per year, with one hospitalization every 3 years [13]. Fibromyalgia
    [Show full text]
  • Prevention of Succinylcholine Induced Postoperative Myalgia by Pretreatment with Lignocaine: a Randomized Controlled Study
    Faridpur Med. Coll. J. 2019;14(1):13-15 Original Article Prevention of Succinylcholine Induced Postoperative Myalgia by Pretreatment with Lignocaine: A Randomized Controlled Study MS Hossain1, L Sanjowal2, MM Rashid3, MAR Babu4, D Saha5 Abstract: Succinylcholine, a depolarizing muscle relaxant possesses a unique property of rapid onset and short duration of action, but is accompanied by side effects such as fasciculation and myalgia. The aim of this study was to investigate the prophylactic effect of intravenous lignocaine on the incidence and severity of succinylcholine-induced postoperative myalgia. This was a randomized controlled double blind study conducted at National Institute of ENT Dhaka, during September to December 2017. Eighty adult patients of American Society of Anesthesiologists status I and II of both sexes for elective surgery under general anesthesia were randomly allocated into two equal groups, lignocaine group and normal saline group. The patients of lignocaine group were pretreated with lignocaine 1.5 mg/kg body weight in 5 ml volume, while patients of normal saline group were given isotonic saline 0.9% in the same volume (5 ml) intravenously. Thereafter, anesthesia was induced in all patients, by injecting 1.5 mg/kg of fentanyl and 2 mg/kg of propofol intravenously. Following the loss of eyelid reflex, 1.5 mg/kg of succinylcholine was injected intravenously as a muscle relaxant and then the patients were intubated. The incidence and severity of myalgia were assessed by a blinded observer 24 hours after surgery. In terms of demographic data, the results of this study showed that there is no significant difference between patients in both groups (P>0.05).
    [Show full text]